These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 30650564)

  • 21. Prion-induced neuronal damage--the mechanisms of neuronal destruction in the subacute spongiform encephalopathies.
    Giese A; Kretzschmar HA
    Curr Top Microbiol Immunol; 2001; 253():203-17. PubMed ID: 11417136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain.
    Bradford BM; McGuire LI; Hume DA; Pridans C; Mabbott NA
    Glia; 2022 Nov; 70(11):2169-2187. PubMed ID: 35852018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroglial patterns are shared by cerebella from prion and prion-like disorder affected patients.
    Garcés M; Guijarro MI; Vargas A; Badiola JJ; Monzón M
    Mech Ageing Dev; 2019 Dec; 184():111176. PubMed ID: 31689427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microglia in Prion Diseases: Angels or Demons?
    Peggion C; Stella R; Lorenzon P; Spisni E; Bertoli A; Massimino ML
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glial alterations in human prion diseases: A correlative study of astroglia, reactive microglia, protein deposition, and neuropathological lesions.
    Monzón M; Hernández RS; Garcés M; Sarasa R; Badiola JJ
    Medicine (Baltimore); 2018 Apr; 97(15):e0320. PubMed ID: 29642165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid associated proteins in Alzheimer's and prion disease.
    Veerhuis R; Boshuizen RS; Familian A
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):235-48. PubMed ID: 15975027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion disease pathogenesis in the absence of the commensal microbiota.
    Bradford BM; Tetlow L; Mabbott NA
    J Gen Virol; 2017 Jul; 98(7):1943-1952. PubMed ID: 28708055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prion Strain Differences in Accumulation of PrPSc on Neurons and Glia Are Associated with Similar Expression Profiles of Neuroinflammatory Genes: Comparison of Three Prion Strains.
    Carroll JA; Striebel JF; Rangel A; Woods T; Phillips K; Peterson KE; Race B; Chesebro B
    PLoS Pathog; 2016 Apr; 12(4):e1005551. PubMed ID: 27046083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astrocyte-to-neuron intercellular prion transfer is mediated by cell-cell contact.
    Victoria GS; Arkhipenko A; Zhu S; Syan S; Zurzolo C
    Sci Rep; 2016 Feb; 6():20762. PubMed ID: 26857744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the reactive states of astrocytes in prion diseases.
    Baskakov IV
    Prion; 2021 Dec; 15(1):87-93. PubMed ID: 34057026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microglia-Specific Metabolic Changes in Neurodegeneration.
    Aldana BI
    J Mol Biol; 2019 Apr; 431(9):1830-1842. PubMed ID: 30878483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the immune system in prion infection.
    Mabbott NA; Alibhai JD; Manson J
    Handb Clin Neurol; 2018; 153():85-107. PubMed ID: 29887157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unaltered prion disease in mice lacking developmental endothelial locus-1.
    Zhu C; Li Z; Li B; Pfammatter M; Hornemann S; Aguzzi A
    Neurobiol Aging; 2019 Apr; 76():208-213. PubMed ID: 30743056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.
    Sakai K; Hasebe R; Takahashi Y; Song CH; Suzuki A; Yamasaki T; Horiuchi M
    J Virol; 2013 Dec; 87(24):13433-45. PubMed ID: 24089559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular pathogenesis of prion diseases.
    Kretzschmar HA
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():56-63. PubMed ID: 10654101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes.
    Kwon HS; Koh SH
    Transl Neurodegener; 2020 Nov; 9(1):42. PubMed ID: 33239064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell adhesion molecule CD44 is dispensable for reactive astrocyte activation during prion disease.
    Bradford BM; Walmsley-Rowe L; Reynolds J; Verity N; Mabbott NA
    Sci Rep; 2024 Jun; 14(1):13749. PubMed ID: 38877012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice.
    Song CH; Furuoka H; Kim CL; Ogino M; Suzuki A; Hasebe R; Horiuchi M
    J Gen Virol; 2008 Jun; 89(Pt 6):1533-1544. PubMed ID: 18474571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation.
    Hughes MM; Field RH; Perry VH; Murray CL; Cunningham C
    Glia; 2010 Dec; 58(16):2017-30. PubMed ID: 20878768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.